In addition, PD-L1 (Programmed Cell Death Ligand 1) and PD-L2 (Programmed Cell Death Ligand 2) from TAMs or tumor cells promote the inhibitory function of the PD-1(Programmed Cell Death Protein 1) immune checkpoint in T cells [13, 14]. The gene discussed is PDCD1; the disease is neoplasm.